Patent

Case Study: Recently Granted Epitope-Based Antibody Patents in the United States, Europe and Japan

Patents involving antibody medicines (antibody patents) are largely grouped into patents specified by antibody amino acid sequences (antibody sequence-based patents) and those not (non-sequence-based patents). Non-sequence-based patents have a broad scope and are thus very useful for protecting antibody medicines. Here, I investigate a recent trend in antibody patents characterized by an antibody-binding site in an antigen.

Full Article Available Here

Related Posts

No results found

Leave a Reply

Menu